We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00687687
First Posted: June 2, 2008
Last Update Posted: August 7, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Gynecologic Oncology Group
Information provided by (Responsible Party):
Sanofi
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: June 15, 2012
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):